Trident Texofab Ltd - 540726 - Cancellation of Board Meeting
The Board Meeting to be held on 23/03/2020 Stands Cancelled.21-03-2020
21-03-2020
Trident Texofab Ltd - 540726 - Closure of Trading Window
Trident Texofab Limited has submitted that the trading window for dealing in Equity Shares of the Company by all Designated Persons covered under Company's Code of Conduct for Prevention of Insider Trading in Securities will be closed from Wednesday, April 01, 2020 till 48 hours after the declaration of Financial Results for the quarter and year ending on March 31, 2020. Please take the same on your records.21-03-2020
Trident Texofab Ltd - 540726 - Closure of Trading Window
Trident Texofab Limited has submitted that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, read with Code of Conduct framed by the Company, the trading window will remain closed for all designated persons covered under Company''s Code of Conduct for Prevention of Insider Trading in Securities from March 14, 2020 to March 25, 2020 (both days inclusive). Kindly take the same on your record. Thank you.14-03-2020
Trident Texofab Ltd - 540726 - Update on board meeting
The Board Meeting to be held on 23/03/2020 has been revised to 23/03/2020 The Board Meeting to be held on 23/03/2020 has been revised to 23/03/2020. As per previous intimation of board meeting of separate meeting of independent directors will be held on same date as specified in it i.e. 23.03.2020 at 12.00 p.m. This intimation is pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, March 23, 2020 at 1.00 P.M. at the registered office of the Company, inter alia including- 1. To discuss and approve the conversion of Compulsorily Convertible Cumulative Preference Shares (CCPS) into Equity Shares issued on Preferential Basis to Promoters and non promoters of the Company as per SEBI (ICDR) Regulations, 2018. So kindly take the same on your record.14-03-2020
Trident Texofab Ltd - 540726 - Board Meeting Intimation for Separate Meeting Of The Independent Directors
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/03/2020 ,inter alia, to consider and approve 1. To review the performance of non-independent directors and the board of directors as a whole; 2. To review the performance of the chairman of the Company, taking into account the views of executive directors and non-executive directors. 3. To assess the quality, quantity and timeliness of flow of information between the management of the Company and the board of directors that is necessary for the board of directors to effectively and reasonably perform their duties. 4. Any other business with the permission of chair arising out of above business and incidental and ancillary to the business.14-03-2020
Trident Texofab Ltd - 540726 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Maniya Hardik Desai14-03-2020
Trident Texofab Ltd - 540726 - Disclosure Under Regulation 29(2) And (3) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Trident Texofab Limited has submitted disclosure received from Mrs. Maniya H. Desai in terms of regulation 29 (2) & (3) in the format prescribed. This is for your information and record. Thanking you.13-03-2020
Trident Texofab Ltd - 540726 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chetan Chandrakant Jariwala27-02-2020
Trident Texofab Ltd - 540726 - Disclosure Under Regulation 29(2) And (3) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Trident Texofab Limited has submitted disclosure as received from Mr. Chetan Jariwala in terms of sub regulation 29 (2) & (3) in the format prescribed. This is for your information and record. Thanking you.27-02-2020
Trident Texofab Ltd - 540726 - Disclosure Under Regulation 7(2) Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015
Trident Texofab Limited has submitted disclosure in Form C as received from Mr. Chetan Chandrakant Jariwala, Promoter cum Whole Time Director in terms of regulation 7(2) of said regulation. This is for your information and record. Thanking you.27-02-2020